The evolutionary history of post-melphalan myeloid neoplasms

Dr Ross Levine on deciphering and targeting clonal evolution in myeloid malignanciesПодробнее

The evolutionary history of cancerПодробнее

Understanding the Life History of Multiple Myeloma Using Whole Genome SequencingПодробнее

Understanding the evolution from haematopoietic stem cell to leukemic cellПодробнее

Mechanisms driving the rapid evolution of cancer genomesПодробнее

The mutagenic impact of melphalan in myelomaПодробнее

Measuring the evolution of neoplasms through single cell approaches to predict disease progressionПодробнее

The origins of therapy-related myeloid neoplasmsПодробнее

Dr. Ross Levine on deciphering and targeting clonal evolution in myeloid malignanciesПодробнее

Michael Stratton: Evolution of the Cancer GenomeПодробнее

All About Pepaxto (Melphalan Flufenamide) #myelomaПодробнее

Tumor Evolution in the Transcriptome, Epigenome, and EpitranscriptomeПодробнее

WHO Update on Myeloid Neoplasms – Dr. Nahlah Alghasham (Sep 30-Oct 1, 2022)Подробнее

Mutational burden at relapse following exposure to high dose melphalan in multiple myelomaПодробнее

The evolution of stem cell transplantationПодробнее

AutoSCT for elderly patients with multiple myeloma in their last quarter of lifeПодробнее

Navigating the genomic landscape of myeloid neoplasmsПодробнее

Webinar 3: Digital Pathology - Myeloid NeoplasmsПодробнее

‘Rebel Cell: Cancer, Evolution and the Science of Life’ by Dr Kat ArneyПодробнее